Date | Time | Source | Announcement |
---|---|---|---|
17 Mar 2010 | 07:00 AM | Sales and Distribution Agreem | |
15 Mar 2010 | 11:07 AM | ValiRx announces good stabili | |
09 Mar 2010 | 07:00 AM | Funding and Partnership Agree | |
05 Mar 2010 | 03:00 PM | Issue of Equity | |
26 Feb 2010 | 04:30 PM | Total Voting Rights | |
16 Feb 2010 | 09:00 AM | Issue of Equity | |
29 Jan 2010 | 10:10 AM | Total Voting Rights | |
19 Jan 2010 | 07:00 AM | GeneICE Update | |
13 Jan 2010 | 07:56 AM | Issue of Equity | |
31 Dec 2009 | 08:03 AM | Issue of Equity | |
30 Dec 2009 | 01:57 PM | Result of General Meeting | |
22 Dec 2009 | 12:19 PM | Regional Funding | |
11 Dec 2009 | 07:42 AM | £3m Equity Purchase Agreemen | |
04 Dec 2009 | 10:14 AM | Notice of General Meeting | |
25 Nov 2009 | 07:00 AM | Trading Update | |
28 Sep 2009 | 07:40 AM | Half Yearly Report | |
14 Sep 2009 | 07:00 AM | New Distribution Venture & Tr | |
29 Jul 2009 | 08:06 AM | Australian Patent Acceptance | |
03 Jul 2009 | 10:57 AM | Result of AGM | |
10 Jun 2009 | 01:35 PM | Final Results | |
10 Jun 2009 | 08:50 AM | Award for cancer therapeutics | |
29 May 2009 | 07:00 AM | Placing Summary and Total Vot | |
11 May 2009 | 07:00 AM | Issue of Equity | |
05 May 2009 | 01:00 PM | Issue of Equity | |
30 Apr 2009 | 07:00 AM | Total Voting Rights | |
27 Apr 2009 | 07:00 AM | Issue of Equity | |
16 Apr 2009 | 03:05 PM | Holding(s) in Company | |
16 Apr 2009 | 07:00 AM | Issue of Equity | |
09 Apr 2009 | 07:00 AM | Issue of Equity | |
06 Apr 2009 | 09:59 AM | Holding(s) in Company | |
31 Mar 2009 | 07:00 AM | Update to the Sale of Shares | |
31 Mar 2009 | 07:00 AM | Issue of Equity and Directors | |
12 Mar 2009 | 07:00 AM | ValiRx Announces Promising In | |
27 Feb 2009 | 07:00 AM | Total Voting Rights | |
13 Feb 2009 | 10:52 AM | Result of EGM | |
30 Jan 2009 | 07:00 AM | Total Voting Rights | |
29 Jan 2009 | 12:07 PM | Availability of circular | |
28 Jan 2009 | 11:55 AM | Proposed Reorganisation and G | |
05 Jan 2009 | 02:50 PM | Issue of Equity | |
31 Dec 2008 | 09:00 AM | Total Voting Rights | |
15 Dec 2008 | 07:00 AM | Global Distribution Agreement | |
05 Dec 2008 | 02:00 PM | Change of Adviser | |
27 Nov 2008 | 04:19 PM | Issue of Equity | |
16 Sep 2008 | 07:00 AM | Update on cancer detection te | |
11 Sep 2008 | 07:00 AM | Interim Results | |
10 Sep 2008 | 10:33 AM | Notice of Results | |
18 Aug 2008 | 04:02 PM | Appointment of director | |
31 Jul 2008 | 07:00 AM | Total Voting Rights | |
28 Jul 2008 | 02:48 PM | AGM Statement | |
23 Jul 2008 | 04:02 PM | Director's Dealing |
ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)
ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.
As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.
The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.
In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.